Loading...

Burcon NutraScience

TSX:BU
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
BU
TSX
CA$14M
Market Cap
  1. Home
  2. CA
  3. Materials
Company description

Burcon NutraScience Corporation, together with its subsidiary, develops plant protein extraction and purification technology of functional and renewable plant proteins in Canada. The last earnings update was 34 days ago. More info.


Add to Portfolio Compare Print
  • Burcon NutraScience has significant price volatility in the past 3 months.
BU Share Price and Events
7 Day Returns
-14.5%
TSX:BU
-0.2%
CA Chemicals
0.3%
CA Market
1 Year Returns
-44%
TSX:BU
9.8%
CA Chemicals
0.7%
CA Market
BU Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Burcon NutraScience (BU) -14.5% 41.3% 132.1% -44% -90.7% -93%
CA Chemicals -0.2% 0.7% 16.4% 9.8% 48.4% -5.6%
CA Market 0.3% 2% 13.2% 0.7% 16.6% 5.6%
1 Year Return vs Industry and Market
  • BU underperformed the Chemicals industry which returned 9.8% over the past year.
  • BU underperformed the Market in Canada which returned 0.7% over the past year.
Price Volatility
BU
Industry
5yr Volatility vs Market

BU Value

 Is Burcon NutraScience undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Burcon NutraScience is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Burcon NutraScience has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Burcon NutraScience. This is due to cash flow or dividend data being unavailable. The share price is CA$0.325.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Burcon NutraScience's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Burcon NutraScience's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSX:BU PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CAD CA$-0.11
TSX:BU Share Price ** TSX (2019-03-20) in CAD CA$0.33
Canada Chemicals Industry PE Ratio Median Figure of 6 Publicly-Listed Chemicals Companies 9.3x
Canada Market PE Ratio Median Figure of 542 Publicly-Listed Companies 14.78x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Burcon NutraScience.

TSX:BU PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:BU Share Price ÷ EPS (both in CAD)

= 0.33 ÷ -0.11

-2.85x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Burcon NutraScience is loss making, we can't compare its value to the CA Chemicals industry average.
  • Burcon NutraScience is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Burcon NutraScience's expected growth come at a high price?
Raw Data
TSX:BU PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.85x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Chemicals Industry PEG Ratio Median Figure of 49 Publicly-Listed Chemicals Companies 1.47x
Canada Market PEG Ratio Median Figure of 253 Publicly-Listed Companies 1.2x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Burcon NutraScience, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Burcon NutraScience's assets?
Raw Data
TSX:BU PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CAD CA$-0.02
TSX:BU Share Price * TSX (2019-03-20) in CAD CA$0.33
Canada Chemicals Industry PB Ratio Median Figure of 29 Publicly-Listed Chemicals Companies 1.34x
Canada Market PB Ratio Median Figure of 2,349 Publicly-Listed Companies 1.58x
TSX:BU PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:BU Share Price ÷ Book Value per Share (both in CAD)

= 0.33 ÷ -0.02

-17.96x

* Primary Listing of Burcon NutraScience.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Burcon NutraScience has negative assets, we can't compare the value of its assets to the CA Chemicals industry average.

Next steps:

  1. Take a look at our analysis of BU’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Burcon NutraScience's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Chemicals industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Burcon NutraScience's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Burcon NutraScience has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

BU Future Performance

 How is Burcon NutraScience expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Burcon NutraScience has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
28.4%
Expected Chemicals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Burcon NutraScience expected to grow at an attractive rate?
  • Unable to compare Burcon NutraScience's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Burcon NutraScience's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Burcon NutraScience's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
TSX:BU Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 28.4%
Canada Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.2%
Canada Market Earnings Growth Rate Market Cap Weighted Average 17.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSX:BU Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSX:BU Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
TSX:BU Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2018-12-31 0 -4 -5
2018-09-30 0 -5 -5
2018-06-30 0 -5 -5
2018-03-31 0 -5 -6
2017-12-31 0 -4 -6
2017-09-30 0 -4 -5
2017-06-30 0 -5 -6
2017-03-31 0 -5 -6
2016-12-31 0 -5 -6
2016-09-30 0 -5 -6
2016-06-30 0 -5 -6
2016-03-31 0 -5 -7

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Burcon NutraScience is high growth as no earnings estimate data is available.
  • Unable to determine if Burcon NutraScience is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSX:BU Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Burcon NutraScience Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:BU Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
TSX:BU Past Financials Data
Date (Data in CAD Millions) EPS *
2018-12-31 -0.11
2018-09-30 -0.13
2018-06-30 -0.13
2018-03-31 -0.15
2017-12-31 -0.15
2017-09-30 -0.15
2017-06-30 -0.15
2017-03-31 -0.16
2016-12-31 -0.17
2016-09-30 -0.18
2016-06-30 -0.18
2016-03-31 -0.18

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Burcon NutraScience will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of BU’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Burcon NutraScience's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Materials companies here
  3. Burcon NutraScience's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Burcon NutraScience's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Burcon NutraScience has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

BU Past Performance

  How has Burcon NutraScience performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Burcon NutraScience's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Burcon NutraScience does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Burcon NutraScience's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Burcon NutraScience's 1-year growth to the North America Chemicals industry average as it is not currently profitable.
Earnings and Revenue History
Burcon NutraScience's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Burcon NutraScience Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:BU Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 0.04 -4.93 1.97 1.62
2018-09-30 0.04 -5.29 2.05 1.68
2018-06-30 0.03 -5.27 1.93 1.77
2018-03-31 0.05 -5.62 2.05 1.85
2017-12-31 0.05 -5.59 1.90 1.97
2017-09-30 0.07 -5.46 2.23 1.98
2017-06-30 0.08 -5.62 2.38 2.05
2017-03-31 0.09 -5.78 2.40 2.15
2016-12-31 0.11 -6.02 2.53 2.24
2016-09-30 0.11 -6.30 2.48 2.43
2016-06-30 0.11 -6.40 2.64 2.48
2016-03-31 0.11 -6.57 2.73 2.56
2015-12-31 0.10 -6.50 3.27 2.58
2015-09-30 0.11 -6.66 3.76 2.55
2015-06-30 0.11 -6.94 4.31 2.57
2015-03-31 0.11 -6.58 2.71 2.45
2014-12-31 0.10 -6.28 4.19 2.38
2014-09-30 0.10 -5.99 4.06 2.33
2014-06-30 0.10 -5.77 3.87 2.30
2014-03-31 0.09 -5.96 4.04 2.31
2013-12-31 0.09 -6.13 4.08 2.33
2013-09-30 0.08 -6.34 4.19 2.31
2013-06-30 0.05 -6.09 3.91 2.31
2013-03-31 0.03 -5.55 3.64 2.02
2012-12-31 0.01 -5.23 3.61 1.72
2012-09-30 -5.37 3.88 1.60
2012-06-30 -5.81 4.69 1.24
2012-03-31 -5.96 5.10 1.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Burcon NutraScience has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Burcon NutraScience has efficiently used its assets last year compared to the CA Chemicals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Burcon NutraScience improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess Burcon NutraScience's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Burcon NutraScience has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

BU Health

 How is Burcon NutraScience's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Burcon NutraScience's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Burcon NutraScience's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Burcon NutraScience has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Burcon NutraScience's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Burcon NutraScience has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Burcon NutraScience Company Filings, last reported 2 months ago.

TSX:BU Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 -0.80 2.47 0.75
2018-09-30 0.30 1.95 1.12
2018-06-30 1.34 1.93 2.13
2018-03-31 2.35 1.91 3.42
2017-12-31 0.25 1.88 1.29
2017-09-30 1.66 1.86 2.33
2017-06-30 2.81 1.84 3.46
2017-03-31 4.11 1.82 4.70
2016-12-31 5.38 1.80 5.85
2016-09-30 1.38 1.77 1.71
2016-06-30 2.68 1.75 2.95
2016-03-31 4.11 0.00 2.48
2015-12-31 5.19 0.00 3.29
2015-09-30 6.47 0.00 4.43
2015-06-30 7.56 0.00 5.64
2015-03-31 5.79 0.00 3.67
2014-12-31 5.24 0.00 2.95
2014-09-30 6.69 0.00 4.18
2014-06-30 8.04 0.00 5.41
2014-03-31 4.32 0.00 1.39
2013-12-31 5.47 0.00 2.55
2013-09-30 6.73 0.00 3.96
2013-06-30 8.25 0.00 5.41
2013-03-31 9.75 0.00 6.69
2012-12-31 11.06 0.00 7.84
2012-09-30 7.28 0.00 3.98
2012-06-30 8.45 0.00 5.06
2012-03-31 9.39 0.00 6.16
  • Burcon NutraScience has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Burcon NutraScience's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Burcon NutraScience has less than a year of cash runway based on current free cash flow.
  • Burcon NutraScience has less than a year of cash runway if free cash flow continues to reduce at historical rates of -4.6% each year.
X
Financial health checks
We assess Burcon NutraScience's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Burcon NutraScience has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

BU Dividends

 What is Burcon NutraScience's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Burcon NutraScience dividends.
If you bought CA$2,000 of Burcon NutraScience shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Burcon NutraScience's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Burcon NutraScience's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSX:BU Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 55 Stocks 2.3%
Canada Market Average Dividend Yield Market Cap Weighted Average of 330 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

TSX:BU Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Burcon NutraScience has not reported any payouts.
  • Unable to verify if Burcon NutraScience's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Burcon NutraScience's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Burcon NutraScience has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Burcon NutraScience's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Burcon NutraScience afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Burcon NutraScience has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

BU Management

 What is the CEO of Burcon NutraScience's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Johann Tergesen
COMPENSATION CA$294,024
AGE 55
TENURE AS CEO 0.2 years
CEO Bio

Mr. Johann Franz Tergesen, MBA, CPA, CA, serves as the President and Chief Operating Officer of Burcon NutraScience Corporation (formerly Burcon Capital Corp.) and serves as the Chief Executive Officer since January 15, 2019. Mr. Tergesen serves as the Chief Executive Officer at Buyatab Online Inc. He served as Vice President and Treasurer of Burcon Properties Limited. He has been with the Burcon group of companies since December of 1995. He served as a Manager in the corporate finance group of the Vancouver office of Coopers & Lybrand, Chartered Accountants. He serves as Director at Buyatab Online Inc. He served as a Director at Burcon NutraScience Corporation since November 3, 1998 to September 12, 2012. He served as a Director of West Fourth Capital Corporation since May 17, 2007. He has been a Member of Advisory Board at Functional Technologies Corp. since March 2008. Mr. Tergesen holds a B.A. in economics from the University of Winnipeg and an M.B.A. from McGill University and is a Member of the Canadian Institute of Chartered Accountants.

CEO Compensation
  • Johann's compensation has been consistent with company performance over the past year.
  • Johann's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure of the Burcon NutraScience management team in years:

9.5
Average Tenure
  • The average tenure for the Burcon NutraScience management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Johann Tergesen

TITLE
President
COMPENSATION
CA$294K
AGE
55
TENURE
0.2 yrs

Jade Cheng

TITLE
CFO & Treasurer
COMPENSATION
CA$193K

Dorothy Law

TITLE
Senior VP of Legal & Corporate Secretary
COMPENSATION
CA$145K
AGE
49
TENURE
9.5 yrs

Randy Willardsen

TITLE
Senior Vice President of Process
COMPENSATION
CA$142K
TENURE
17.3 yrs

Martin Schweizer

TITLE
Vice President of Technical Development
COMPENSATION
CA$183K
TENURE
9.5 yrs
Board of Directors Tenure

Average tenure and age of the Burcon NutraScience board of directors in years:

5.3
Average Tenure
75
Average Age
  • The tenure for the Burcon NutraScience board of directors is about average.
Board of Directors

David Lorne Tyrrell

TITLE
Chairman & Lead Director
COMPENSATION
CA$31K
AGE
75
TENURE
0.2 yrs

Doug Gilpin

TITLE
Director
COMPENSATION
CA$33K
AGE
79
TENURE
7.5 yrs

Rosanna Chau

TITLE
Director
COMPENSATION
CA$23K
AGE
63
TENURE
20.3 yrs

Alan Chan

TITLE
Director
COMPENSATION
CA$22K
TENURE
8.9 yrs

Peter Kappel

TITLE
Director
COMPENSATION
CA$32K
TENURE
3.2 yrs

David Ju

TITLE
Independent Director
COMPENSATION
CA$21K
TENURE
1.3 yrs

Paul Westdal

TITLE
Director Emeritus
COMPENSATION
CA$5K
Who owns this company?
Recent Insider Trading
  • Burcon NutraScience insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
17. Jan 19 Buy PT International Development Corporation Limited Company 14. Jan 19 14. Jan 19 1,566,719 CA$0.20 CA$311,778
16. Jan 19 Sell Allan Yap Individual 14. Jan 19 14. Jan 19 -1,566,719 CA$0.20 CA$-313,344
08. Jan 19 Buy Johann Tergesen Individual 04. Jan 19 04. Jan 19 20,000 CA$0.16 CA$3,200
20. Dec 18 Buy Johann Tergesen Individual 19. Dec 18 19. Dec 18 50,000 CA$0.15 CA$7,050
18. Dec 18 Buy Johann Tergesen Individual 17. Dec 18 18. Dec 18 120,000 CA$0.17 CA$19,001
17. Dec 18 Buy Johann Tergesen Individual 11. Dec 18 14. Dec 18 70,000 CA$0.23 CA$15,441
X
Management checks
We assess Burcon NutraScience's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Burcon NutraScience has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

BU News

Simply Wall St News

What does Burcon Nutrascience Corporation's (TSE:BU) Balance Sheet Tell Us About Its Future?

Burcon Nutrascience Corporation (TSE:BU) is a small-cap stock with a market capitalization of CA$23.73m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health.

Simply Wall St -

Who Owns Burcon Nutrascience Corporation (TSE:BU)?

In this article, I'm going to take a look at Burcon Nutrascience Corporation’s (TSX:BU) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … Insider Ownership Insiders form another group of important ownership types as they manage the company's operations and decide the best use of capital. … Private Company Ownership Potential investors in BU should also look at another important group of investors: private companies, with a stake of 4.15%, who are primarily invested because of strategic and capital gain interests.

Simply Wall St -

Should You Worry About Burcon Nutrascience Corporation's (TSE:BU) CEO Salary Level?

Profitability of a company is a strong indication of BU's ability to generate returns on shareholders' funds through corporate activities. … Normally I would use earnings and market cap to account for variations in performance, however, BU's negative earnings reduces the usefulness of my formula. … Its important for shareholders to be active in voting governance decisions, as board members are only representatives of investors' voices.

Simply Wall St -

How Should You Think About Burcon Nutrascience Corporation's (TSE:BU) Risks?

A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … See our latest analysis for Burcon Nutrascience What does BU's beta value mean? … Thus, we can expect BU to be more stable in the face of market movements, relative to its peers of similar size but with a higher portion of fixed assets on their books.

Simply Wall St -

Is Burcon Nutrascience Corporation (TSE:BU) Growing Too Fast?

Looking at Burcon Nutrascience’s latest financial data, I will gauge when the company may run out of cash and need to raise more money. … Given the level of cash left in the bank, if Burcon Nutrascience maintained its opex level of CA$3.86M, it will still run out of cash within the next couples of months. … The cash burn analysis result indicates a cash constraint for the company, due to its current level of cash reserves.

Simply Wall St -

Are Earnings Prospects Improving For Loss-Making Burcon Nutrascience Corporation's (TSE:BU)?

Check out our latest analysis for Burcon Nutrascience Could BU beat the long-term trend and outperform its industry? … TSX:BU Income Statement Mar 22nd 18 We can further analyze Burcon Nutrascience's loss by looking at what the industry has been experiencing over the past few years. … Each year, for the past five years Burcon Nutrascience's top-line has increased by a mere 7.75%, on average.

Simply Wall St -

What Investors Should Know About Burcon Nutrascience Corporation's (TSE:BU) Financial Strength

How does BU’s operating cash flow stack up against its debt? … Moving onto cash from operations, its operating cash flow is not yet significant enough to calculate a meaningful cash-to-debt ratio, indicating that operational efficiency is something we’d need to take a look at. … Running high debt, while not yet making money, can be risky in unexpected downturns as liquidity may dry up, making it hard to operate.Next Steps: BU’s debt and cash flow levels indicate room for improvement.

Simply Wall St -

Is Burcon Nutrascience Corporation (TSE:BU) Overpaying Its CEO?

Usually I would use earnings and market cap to account for variations in performance, however, BU's negative earnings reduces the effectiveness of this method. … Although remuneration can be a useful gauge of whether Yap's incentives are well-aligned with BU's shareholders, it is certainly not sufficient to base your investment decision solely on this factor. … To research more about these fundamentals, I recommend you check out our simple infographic report on BU's financial metrics.

Simply Wall St -

Is This A Catalyst To Buy Burcon Nutrascience Corporation (TSE:BU)?

Burcon Nutrascience faces the trade-off between running the risk of depleting its cash reserves too fast, or risk falling behind its profitable competitors by investing too slowly. … TSX:BU Income Statement Dec 18th 17 When will Burcon Nutrascience need to raise more cash? … However, even with declining costs, the current level of cash is not enough to sustain Burcon Nutrascience’s operations and the company may need to come to market to raise more capital within the year.

Simply Wall St -

Want To Invest In Burcon Nutrascience Corporation (TSX:BU)? Here's How It Performed Lately

Investors with a long-term horizong may find it valuable to assess Burcon Nutrascience Corporation's (TSX:BU) earnings trend over time and against its industry benchmark as opposed to simply looking at a sincle earnings announcement at one point in time. … I look at data from the most recent 12 months, which annualizes the most recent half-year data, or in some cases, the latest annual report is already the most recent financial year data. … Burcon Nutrascience's latest twelve-month earnings -CA$5.5M, which, in comparison to the prior year's figure, has become less negative.

Simply Wall St -

BU Company Info

Description

Burcon NutraScience Corporation, together with its subsidiary, develops plant protein extraction and purification technology of functional and renewable plant proteins in Canada. Its products include CLARISOY, a soy protein for dairy foods, neutral pH beverages, and coffee creamers/whiteners; and Peazazz, a novel pea protein isolate. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation was founded in 1998 and is headquartered in Vancouver, Canada.

Details
Name: Burcon NutraScience Corporation
BU
Exchange: TSX
Founded: 1998
CA$14,280,998
43,941,535
Website: http://www.burcon.ca
Address: Burcon NutraScience Corporation
1946 West Broadway,
Vancouver,
British Columbia, V6J 1Z2,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX BU Common Shares The Toronto Stock Exchange CA CAD 19. Feb 1999
OTCPK BURO.F Common Shares Pink Sheets LLC US USD 19. Feb 1999
DB BNE Common Shares Deutsche Boerse AG DE EUR 19. Feb 1999
Number of employees
Current staff
Staff numbers
21
Burcon NutraScience employees.
Industry
Specialty Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/03/20 23:33
End of day share price update: 2019/03/20 00:00
Last estimates confirmation: 2016/06/27
Last earnings filing: 2019/02/14
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.